ArticleBMC cancer2019

Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.

Gemma Bruera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.